Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fedora Pharmaceuticals Inc.

www.fedorapharma.com

Latest From Fedora Pharmaceuticals Inc.

Asia Deal Watch: Boost For Esperion's Cholesterol Candidate As Daiichi Brought On Board

Daiichi Sankyo pays $150m upfront to commercialize Esperion's cholesterol drug and combination in Europe, while Gilead enters major deal worth up to $785m with Korea's Yuhan to bolster its NASH portfolio. Samsung taps 3SBio to build its biosimilars business in China. 
Deals Asia Pacific

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals

Point-Of-Care Testing Stirs Anew

Point-of-care diagnostics are back in favor with investors who believe market forces and technological advances are finally converging in ways that invite success and this time, they may be right. Profiles of GeneWEAVE, HiberGene, Spectromics, and Xagenic.

Medical Device

Antibiotics Crisis Needs Focused Global Approach “Similar To AIDS” – Conference Told

A solution to global antibiotics resistance will need co-ordination, focused drug innovation and the selective use of new medicines, in a manner not unlike that which turned HIV from a terminal illness into a chronic condition, participants at the Pharma Summit 2015 are told.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Fedora Pharmaceuticals Inc.
  • Senior Management
  • Christopher G Micetich, Pres. & CEO
    Gary Roth, CFO
    Sameeh M Salama, PhD, VP, Bus. Dev.
  • Contact Info
  • Fedora Pharmaceuticals Inc.
    Phone: (780) 757-5401
    11629 – 105 Ave. NW
    Edmonton, T5H 0L9
    Canada
UsernamePublicRestriction

Register